Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.
about
Comparison between liposomal formulations of amphotericin B.In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice.Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens.Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice.Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging.Recent Advancements in Combinational Antifungal Therapy and Immunotherapy
P2860
Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Toxicity and efficacy differen ...... illus fumigatus infected mice.
@en
type
label
Toxicity and efficacy differen ...... illus fumigatus infected mice.
@en
prefLabel
Toxicity and efficacy differen ...... illus fumigatus infected mice.
@en
P2093
P2860
P356
P1433
P1476
Toxicity and efficacy differen ...... illus fumigatus infected mice.
@en
P2093
G M Jensen
J A Schwartz
J P Adler-Moore
P2860
P304
P356
10.1093/MMY/MYU070
P577
2014-12-30T00:00:00Z